Lycia Therapeutics, Inc. (LYCA)

Lycia Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Lycia Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-30.03	-36.46	-26.5
Depreciation & Amortization	0.97	1.19	1.18
Share-Based Compensation	-	1.1	0.79
Other Operating Activities	-4.7	-17.19	-4.97
Operating Cash Flow	-33.75	-51.36	-29.5
Operating Cash Flow Growth	-	-	-

Investing Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Capital Expenditures	-0.03	-0.19	-1.27
Change in Investments	-	40.12	-58.44
Other Investing Activities	-5.31	0.04	-
Investing Cash Flow	-5.34	39.96	-59.71

Financing Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Share Issuance / Repurchase	-	0.08	106.42
Financing Cash Flow	74.71	0.08	106.42

Net Cash Flow

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Cash Flow	35.62	-11.32	17.21

Free Cash Flow

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-33.79	-51.56	-30.77
Free Cash Flow Growth	-	-	-
Free Cash Flow Margin	-761.83%	-764.81%	-206.03%